VRX: Ackman Cites Buffett In Attack On ChanosVW Staff
Bill Ackman, founder and CEO of Pershing Square Capital Management, addresses what a bad rollup looks like in business, and defends why Valeant Pharmaceuticals is "not just a rollup."
Videos and excerpts below
Bill Ackman, founder and CEO of Pershing Square Capital Management, discusses James Chanos' short thesis of Valeant Pharmaceuticals.
valeant is not just a roll up. let's talk about what a good roll up is. berkshire hathaway. becky asked warren buffett what happens to the rollup when he is gone? it is a serial acquirer over the last 40 years. and it's done a fabulous . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com or click chat button and we will get back to you as quick as humanly possible